A brief motivational intervention for enhancing medication adherence for adolescents with bipolar disorder: A pilot randomized trial.

A brief motivational intervention for enhancing medication adherence for adolescents with bipolar disorder: A pilot randomized trial.
复制标题

DOI:
10.1016/j.jad.2020.01.015
复制
发表时间:
2020-03-15
影响因子:
6.6
通讯作者:
Douaihy A
Douaihy A
中科院分区:
医学2区
文献类型:
--
作者:
Goldstein TR;Krantz ML;Fersch-Podrat RK;Hotkowski NJ;Merranko J;Sobel L;Axelson D;Birmaher B;Douaihy A

文献摘要

参考文献

相似文献

Youth with bipolar disorder (BP) exhibit poor medication adherence, contributing to affective recurrence. Brief Motivational Interventions (BMIs) improve adherence among adolescents with chronic conditions. In an open pilot series, we developed a 3-session BMI for BP adolescents targeting medication adherence and conducted a pilot randomized trial comparing Standard Care (SC) versus SC+BMI. Participants include 43 adolescents with BP prescribed psychotropic medications. We assessed medication adherence objectively via bluetooth-enabled electronic pillbox (MedTracker). A blinded evaluator assessed mood symptoms at intake, 3- and 6-months. The BMI was well-received. Average objective medication adherence increased with time in SC+BMI, but decreased in SC-Alone (p<0.0001). Adolescents’ baseline self-rated expectation of improvement with treatment moderated the effect of treatment on improvement in adherence over time (p=0.003). Across groups, poor adherence predicted increased likelihood of depression and hypo/mania symptoms in the subsequent two weeks; medication adherence mediated the effect of the BMI on the likelihood of depressive symptoms (p=0.007). Electronic pillbox use (across groups) may enhance adherence, resulting in overestimates compared with naturalistic conditions. This pilot randomized trial may have been underpowered to detect some group differences. A BMI offers promise as a disseminable adjunctive intervention for improving medication adherence for adolescents with BP. Future studies with larger samples can establish efficacy.
DOI: 10.1111/bdi.12556
发表时间: 2017-11
期刊: Bipolar disorders
影响因子: 5.4
作者:
Goldstein BI;Birmaher B;Carlson GA;DelBello MP;Findling RL;Fristad M;Kowatch RA;Miklowitz DJ;Nery FG;Perez-Algorta G;Van Meter A;Zeni CP;Correll CU;Kim HW;Wozniak J;Chang KD;Hillegers M;Youngstrom EA
通讯作者: Youngstrom EA
DOI: 10.4088/jcp.15017su1c.02
发表时间: 2016-01-01
影响因子: 5.3
作者:
Findling, Robert L.
通讯作者: Findling, Robert L.
DOI: 10.1097/chi.0b013e3181930660
发表时间: 2009-02-01
影响因子: 13.3
作者:
Dilallo, John J.;Weiss, Gony
通讯作者: Weiss, Gony
DOI: 10.1037/a0016072
发表时间: 2010-04-01
影响因子: 3.3
作者:
Interian, Alejandro;Martinez, Igda;Guarnaccia, Peter J.
通讯作者: Guarnaccia, Peter J.
DOI: 10.1176/appi.ps.201100516
发表时间: 2012-10
期刊: Psychiatric services (Washington, D.C.)
影响因子: --
作者:
Dusetzina SB;Farley JF;Weinberger M;Gaynes BN;Sleath B;Hansen RA
通讯作者: Hansen RA